NEURALINK - A NEW ERA OF MEDICAL ADVANCEMENTS? Neuralink, Elon Musk's brain-implant company, has received approval from the US Food and Drug Administration (FDA) to commence its first in-human clinical study. This marks a significant milestone for Neuralink as it aims to develop a brain implant that can treat severe conditions such as paralysis and blindness. The FDA had initially rejected Neuralink's application due to concerns regarding the device's battery, potential migration of implant wires within the brain, and the safe extraction of the device without causing damage to brain tissue. However, the company seems to have addressed these concerns. We may be staring at a bold future where both disabled and healthy individuals can receive surgical implants to treat various conditions, including obesity, autism, depression, and schizophrenia, as well as to enable capabilities like web browsing and telepathy. With appropriate safeguards in place, the development of innovative medical technologies like Neuralink has the potential to improve the lives of countless individuals, ushering in a new era of medical advancements for the betterment of humanity. (By Sadiq Shaban, Opinion Editor)
REUTER